Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF417 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPHKAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928844 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929709 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCOLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF780B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LUZP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on